Literature DB >> 10147116

Spreadsheet software program to analyse costs beyond drug acquisition price.

J A Paladino1.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 10147116     DOI: 10.2165/00019053-199202030-00007

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  5 in total

1.  Evaluating the cost impact of intravenous antibiotic dosing frequencies.

Authors:  R M Foran; J L Brett; P H Wulf
Journal:  DICP       Date:  1991-05

2.  Cost containment of reconstituted parenteral antibiotics: personnel and supply costs associated with preparation, dispensing, and administration.

Authors:  D J Tanner
Journal:  Rev Infect Dis       Date:  1984 Nov-Dec

3.  Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.

Authors:  L A Mandell; M G Bergeron; A R Ronald; C Vega; G Harding; R Saginur; R Feld; R Duperval; S J Landis; L J Miedzinski
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

4.  Is there cost reduction potential for extended half-life cephalosporins?

Authors:  R D Scalley; C C Stuart
Journal:  Drug Intell Clin Pharm       Date:  1986-12

5.  The pharmacoeconomics of renal transplantation: increased drug costs with decreased hospitalization costs.

Authors:  D M Canafax; S A Gruber; G L Chan; C J Miles; A J Matas; J S Najarian; R J Cipolle
Journal:  Pharmacotherapy       Date:  1990       Impact factor: 4.705

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.